Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China
· Delayed Price · Currency is CNY 22.95
+0.42 (1.86%)
Apr 29, 2026, 3:00 PM CST
SHA:605033 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 3,103 | 2,715 | 1,626 | 2,427 | 2,359 | 3,611 | Upgrade
|
| Market Cap Growth | 29.95% | 66.92% | -32.98% | 2.88% | -34.67% | - | Upgrade
|
| Enterprise Value | 2,489 | 2,222 | 1,176 | 2,126 | 2,060 | 3,339 | Upgrade
|
| Last Close Price | 22.95 | 20.08 | 11.94 | 17.54 | 16.53 | 25.60 | Upgrade
|
| PE Ratio | 63.75 | 55.79 | 44.13 | 42.16 | 16.26 | 28.72 | Upgrade
|
| PS Ratio | 3.40 | 2.98 | 1.84 | 3.47 | 2.60 | 4.29 | Upgrade
|
| PB Ratio | 2.69 | 2.35 | 1.45 | 2.18 | 2.17 | 3.74 | Upgrade
|
| P/TBV Ratio | 3.00 | 2.62 | 1.62 | 2.35 | 2.20 | 3.77 | Upgrade
|
| P/FCF Ratio | 69.36 | 60.69 | 13.38 | 18.51 | 137.78 | - | Upgrade
|
| P/OCF Ratio | 13.53 | 11.84 | 5.80 | 7.25 | 18.66 | - | Upgrade
|
| EV/Sales Ratio | 2.73 | 2.44 | 1.33 | 3.04 | 2.27 | 3.96 | Upgrade
|
| EV/EBITDA Ratio | 25.55 | 22.80 | 29.93 | 33.34 | 13.73 | 24.63 | Upgrade
|
| EV/EBIT Ratio | 38.43 | 34.29 | 62.31 | 49.56 | 15.31 | 27.13 | Upgrade
|
| EV/FCF Ratio | 55.65 | 49.66 | 9.67 | 16.22 | 120.32 | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.07 | 0.00 | - | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 1.55 | 1.55 | 1.86 | 0.02 | - | 0.20 | Upgrade
|
| Debt / FCF Ratio | 3.37 | 3.37 | 0.60 | 0.01 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.53 | -0.53 | -0.52 | -0.43 | -0.37 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.30 | -6.30 | -14.84 | -7.53 | -2.66 | -2.77 | Upgrade
|
| Net Debt / FCF Ratio | -13.71 | -13.71 | -4.80 | -3.66 | -23.34 | 1.74 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.50 | 0.43 | 0.60 | 0.75 | Upgrade
|
| Inventory Turnover | 2.41 | 2.41 | 2.12 | 1.18 | 1.04 | 1.27 | Upgrade
|
| Quick Ratio | 1.17 | 1.17 | 1.21 | 1.39 | 1.69 | 1.14 | Upgrade
|
| Current Ratio | 1.64 | 1.64 | 1.78 | 2.33 | 3.21 | 2.73 | Upgrade
|
| Return on Equity (ROE) | 4.27% | 4.27% | 3.29% | 5.23% | 14.13% | 17.76% | Upgrade
|
| Return on Assets (ROA) | 2.06% | 2.06% | 0.66% | 1.65% | 5.56% | 6.84% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.09% | 11.14% | 3.13% | 5.99% | 20.05% | 25.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.80% | 4.80% | 1.50% | 3.50% | 11.30% | 12.00% | Upgrade
|
| Earnings Yield | 1.57% | 1.79% | 2.27% | 2.37% | 6.15% | 3.48% | Upgrade
|
| FCF Yield | 1.44% | 1.65% | 7.48% | 5.40% | 0.73% | -5.96% | Upgrade
|
| Dividend Yield | 0.67% | - | 1.21% | 0.85% | 1.33% | 0.74% | Upgrade
|
| Payout Ratio | 49.51% | 49.51% | 76.62% | 51.82% | 18.38% | 2.62% | Upgrade
|
| Buyback Yield / Dilution | 0.98% | 0.98% | -1.99% | 1.29% | -22.93% | -9.27% | Upgrade
|
| Total Shareholder Return | 1.65% | 0.98% | -0.78% | 2.14% | -21.60% | -8.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.